Trials / Conditions / Hypercholesteremia

Hypercholesteremia

18 registered clinical trials studyying Hypercholesteremia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis NCT07307989	Chang Gung Memorial Hospital	Phase 2
Completed	The Effect of Remote Ischemic Conditioning in Patients With Hypercholesterolemia NCT05164185	Karolinska Institutet	N/A
Completed	The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects NCT03634436	Jiangsu HengRui Medicine Co., Ltd.	Phase 1
Completed	Pediatric Preventative Health Screenings - Obesity and Family-Centered Outcomes NCT02850224	Henry Ford Health System	N/A
Completed	A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity S NCT02634151	NeuroBo Pharmaceuticals Inc.	Phase 2
Completed	Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lo NCT02722408	NeuroBo Pharmaceuticals Inc.	Phase 2
Unknown	Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardi NCT01890889	Integrative Health Technologies, Inc.	N/A
Completed	Pattern of Statins Use in Catalonia NCT01477944	AstraZeneca	—
Completed	Effects of Limicol on LDL-cholesterol NCT01354327	Lescuyer Laboratory	N/A
Completed	C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients NCT00688454	AstraZeneca	—
Completed	Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) NCT00376584	Merck Sharp & Dohme LLC	Phase 3
Completed	Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at NCT00347217	AstraZeneca	—
Completed	Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease NCT00329160	AstraZeneca	Phase 4
Completed	Phytosterol Supplementation and Cardiovascular Risk NCT00153738	The Cooper Institute	N/A
Completed	Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy NCT00239330	AstraZeneca	Phase 3
Completed	Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers NCT02587416	NeuroBo Pharmaceuticals Inc.	Phase 1
Completed	A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR) NCT00225589	AstraZeneca	Phase 3
Completed	Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque NCT00408382	Astellas Pharma Inc	Phase 4